Reverse Remodeling Effects of CDR132L in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Cardiac Hypertrophy
Clinical trial NCT05953831 · WITHDRAWN
Trial details
- NCT number
- NCT05953831
- Sponsor
- Cardior Pharmaceuticals GmbH
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-30
- Primary completion
- 2025-09-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.